RENAISSANCE TECHNOLOGIES LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1037389
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$25,856,058
-$32,038,904 QoQ
Shares Held
451,871
-55.9% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#65
of 561 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. BMRN ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in BMRN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,856,058 | 451,871 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $57,894,962 | 1,024,871 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $78,743,026 | 1,324,971 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $102,555,805 | 1,893,571 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $99,318,201 | 1,806,771 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $63,322,051 | 895,771 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,649,800 | 435,871 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,442,442 | 418,871 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,566,746 | 116,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $47,344,481 | 542,071 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $37,282,817 | 386,671 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $51,475,098 | 581,771 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $63,505,061 | 732,638 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $75,951,344 | 781,071 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $65,226,745 | 630,271 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $63,108,806 | 744,471 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $60,889,809 | 734,763 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $37,869,284 | 491,171 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $57,521,151 | 651,060 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,483,893 | 381,471 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $24,195,180 | 289,971 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $27,604,266 | 365,571 | Shares | Sole | 2021-05-13 | |
| 2020-03-31 | $1,613,950 | 19,100 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||